These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3037186)

  • 21. Neutralization kinetics of poliovirus by specific antiserum during the course of immunization of rabbits.
    Ozaki Y
    Arch Gesamte Virusforsch; 1968; 25(2):137-47. PubMed ID: 4303671
    [No Abstract]   [Full Text] [Related]  

  • 22. Stepwise degradation of poliovirus capsid by alkaline treatment.
    Katagiri S; Aikawa S; Hinuma Y
    J Gen Virol; 1971 Oct; 13(1):101-9. PubMed ID: 4331807
    [No Abstract]   [Full Text] [Related]  

  • 23. A rapid and sensitive micro scale assay for quantitative detection of cell protective effects: application for the isolation of a monoclonal antibody against HeLa cell proteins involved in poliovirus attachment.
    Barnert RH; Zeichhardt H; Habermehl KO
    J Virol Methods; 1991 Nov; 35(1):1-14. PubMed ID: 1666110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of hemorrhagic nephroso-nephritis virus in cell cultures.
    Gavrilyuk BK; Smorodintsev AA
    Arch Gesamte Virusforsch; 1971; 34(3):171-8. PubMed ID: 4107353
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence for conformational changes of poliovirus precursor particles during virus morphogenesis.
    Wiegers KJ; Dernick R
    J Gen Virol; 1985 May; 66 ( Pt 5)():1037-44. PubMed ID: 2582079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of in vitro interference between SA-11 rotavirus and attenuated poliovirus type 1.
    Guiscafré Gallardo JP; Zamora Zavala C; Alvarez y Muñoz T; Muñoz O
    Arch Med Res; 1992; 23(1):51-4. PubMed ID: 1339225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of a cytopathic agent isolated from a patient with subacute sclerosing panencephalitis in Japan.
    Doi Y; Sanpe T; Nakajima M; Okawa S; Koto T
    Jpn J Med Sci Biol; 1972 Oct; 25(5):321-33. PubMed ID: 4349501
    [No Abstract]   [Full Text] [Related]  

  • 28. STUDIES ON THE MECHANISM OF POLIOVIRUS-INDUCED CELL DAMAGE. I. THE RELATION BETWEEN POLIOVIRUS,-INDUCED METABOLIC AND MORPHOLOGICAL ALTERATIONS IN CULTURED CELLS.
    BABLANIAN R; EGGERS HJ; TAMM I
    Virology; 1965 May; 26():100-13. PubMed ID: 14293297
    [No Abstract]   [Full Text] [Related]  

  • 29. Postinfection treatment with antiviral serum results in survival of neural cells productively infected with virulent poliovirus.
    Tolskaya EA; Ivannikova TA; Kolesnikova MS; Drozdov SG; Agol VI
    J Virol; 1992 Aug; 66(8):5152-6. PubMed ID: 1321295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of cellular and viral macromolecules under conditions of suboptimal temperature.
    Ghendon YZ; Ageeva O
    Arch Gesamte Virusforsch; 1970; 30(1):7-15. PubMed ID: 4315826
    [No Abstract]   [Full Text] [Related]  

  • 31. Microepidemiology of mumps virus infection in HeLa cell monolayers.
    Davis CW; Saint Geme JW
    Proc Soc Exp Biol Med; 1972 Feb; 139(2):500-5. PubMed ID: 5059040
    [No Abstract]   [Full Text] [Related]  

  • 32. Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells.
    Wilson T; Papahadjopoulos D; Taber R
    Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3471-5. PubMed ID: 198787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of type 1 poliovirus by electrophoretic analysis.
    Mandel B
    Virology; 1971 Jun; 44(3):554-68. PubMed ID: 4332969
    [No Abstract]   [Full Text] [Related]  

  • 34. Persistent infection of human lymphoid cells with poliovirus and development of temperature-sensitive mutants.
    Carp RI
    Intervirology; 1981; 15(1):49-56. PubMed ID: 6268569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depression of macromolecular synthesis in cells infected with guanidine-dependent poliovirus under restrictive conditions.
    Bablanian R
    Virology; 1972 Jan; 47(1):255-9. PubMed ID: 4333574
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intratypical antigenic differentiation of poliovirus strains circulating in Mali by means of cross-adsorbed sera].
    Pervikov IuV; Fafana Ia; Koldoba LG
    Vopr Virusol; 1978; (4):470-3. PubMed ID: 86237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against viral nonstructural proteins in response to infection with poliovirus.
    Ehrenfeld E; Brown D; Jia XY; Summers DF
    J Infect Dis; 1995 Apr; 171(4):845-50. PubMed ID: 7535829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional and enhanced plaque neutralization assay for polio antibody.
    Boone EJ; Albrecht P
    J Virol Methods; 1983 Apr; 6(4):193-202. PubMed ID: 6306035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of specificity of antibodies contained in antiserum against poliovirus with mutants resistant to inhibitors in equine serum.
    Urasawa S; Urasawa T; Kanamitsu M
    J Immunol; 1974 Aug; 113(2):537-42. PubMed ID: 4367633
    [No Abstract]   [Full Text] [Related]  

  • 40. Biophysical properties of poliovirus particles irradiated with ultraviolet light.
    Katagiri S; Hinuma Y; Ishida N
    Virology; 1967 Jun; 32(2):337-43. PubMed ID: 4290641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.